Literature DB >> 21470135

Metastasis suppressors: basic and translational advances.

C Buchanan1, M A Lago Huvelle, M G Peters.   

Abstract

Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastatic cascade, including cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. As a consequence, they are very important therapeutic targets. This review discusses our current understanding of metastasis suppressors and how this knowledge might be useful to improve the treatment of cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470135     DOI: 10.2174/138920111798376914

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

1.  Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.

Authors:  Dolores Fernández; Macarena Guereño; María Amparo Lago Huvelle; Magalí Cercato; María Giselle Peters
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-28       Impact factor: 4.553

Review 2.  The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets.

Authors:  Wensheng Liu; Zaklina Kovacevic; Zhihai Peng; Runsen Jin; Puxiongzhi Wang; Fei Yue; Minhua Zheng; Michael L-H Huang; Patric J Jansson; Vera Richardson; Danuta S Kalinowski; Darius J R Lane; Angelica M Merlot; Sumit Sahni; Des R Richardson
Journal:  Oncotarget       Date:  2015-11-03

3.  Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.

Authors:  Lilian Fedra Castillo; Rocío Tascón; María Amparo Lago Huvelle; Gisela Novack; María Candelaria Llorens; Ancely Ferreira Dos Santos; Jorge Shortrede; Ana María Cabanillas; Elisa Bal de Kier Joffé; Leticia Labriola; María Giselle Peters
Journal:  Oncotarget       Date:  2016-09-13

Review 4.  Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor.

Authors:  Daqing Wu
Journal:  Genes Dis       Date:  2017-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.